标题
The gut microbiome and liver cancer: mechanisms and clinical translation
作者
关键词
-
出版物
Nature Reviews Gastroenterology & Hepatology
Volume 14, Issue 9, Pages 527-539
出版商
Springer Nature
发表日期
2017-07-05
DOI
10.1038/nrgastro.2017.72
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE 2 -Mediated Suppression of Antitumor Immunity
- (2017) Tze Mun Loo et al. Cancer Discovery
- Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota
- (2017) Da Zhou et al. Scientific Reports
- HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients
- (2016) J. S. Bajaj et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling
- (2016) Avafia Y. Dossa et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model
- (2016) Koichi Achiwa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cirrhosis related functionality characteristic of the fecal microbiota as revealed by a metaproteomic approach
- (2016) Xiao Wei et al. BMC GASTROENTEROLOGY
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
- (2016) Weifei Zhu et al. CELL
- Alcoholic Liver Disease
- (2016) Kartik Joshi et al. Clinics in Liver Disease
- Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
- (2016) Long-Xian Lv et al. ENVIRONMENTAL MICROBIOLOGY
- Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis
- (2016) Asem Elfert et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach
- (2016) Federica Del Chierico et al. HEPATOLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
- (2016) María Úbeda et al. JOURNAL OF HEPATOLOGY
- Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure
- (2016) Rajeshwar P. Mookerjee et al. JOURNAL OF HEPATOLOGY
- Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
- (2016) Veit Rothhammer et al. NATURE MEDICINE
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
- (2016) Bruno Lamas et al. NATURE MEDICINE
- Signals from the gut microbiota to distant organs in physiology and disease
- (2016) Bjoern O Schroeder et al. NATURE MEDICINE
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
- (2016) Jun Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
- (2016) H. Chu et al. SCIENCE
- Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
- (2016) Marialena Mouzaki et al. PLoS One
- Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology
- (2016) Yanfei Chen et al. Scientific Reports
- The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
- (2015) Len Verbeke et al. AMERICAN JOURNAL OF PATHOLOGY
- Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
- (2015) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice
- (2015) Magdalena Mazagova et al. FASEB JOURNAL
- Supplementation of Saturated Long-Chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-induced Liver Injury in Mice
- (2015) Peng Chen et al. GASTROENTEROLOGY
- Gut–Liver Axis in Alcoholic Liver Disease
- (2015) Gyongyi Szabo GASTROENTEROLOGY
- Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
- (2015) James H. Tabibian et al. HEPATOLOGY
- Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice
- (2015) Peng Chen et al. HEPATOLOGY
- Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
- (2015) Jasmohan S. Bajaj et al. HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Decompensated cirrhosis and microbiome interpretation
- (2015) Jasmohan S. Bajaj et al. NATURE
- Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota
- (2015) Han-Hsuan Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- A gut-vascular barrier controls the systemic dissemination of bacteria
- (2015) Ilaria Spadoni et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Nutritional Keys for Intestinal Barrier Modulation
- (2015) Stefania De Santis et al. Frontiers in Immunology
- Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis
- (2014) A. Alisi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial
- (2014) Radha K. Dhiman et al. GASTROENTEROLOGY
- Interactions Between the Intestinal Microbiome and Liver Diseases
- (2014) Bernd Schnabl et al. GASTROENTEROLOGY
- Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation
- (2014) Chiara Degirolamo et al. HEPATOLOGY
- Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
- (2014) Changtao Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
- (2014) Rajiv Jalan et al. JOURNAL OF HEPATOLOGY
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Gut microbiota–generated metabolites in animal health and disease
- (2014) Won-Jae Lee et al. Nature Chemical Biology
- Impact of Rifaximin on the Frequency and Characteristics of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis and Ascites
- (2014) Philipp Lutz et al. PLoS One
- Gastrointestinal dysfunction in liver cirrhosis
- (2014) Evangelos Kalaitzakis WORLD JOURNAL OF GASTROENTEROLOGY
- Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
- (2013) Bjørn S. Madsen et al. ADVANCES IN THERAPY
- A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
- (2013) Barjesh Chander Sharma et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Intestinal microbiota in patients with nonalcoholic fatty liver disease
- (2013) Marialena Mouzaki et al. HEPATOLOGY
- Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
- (2013) Len Verbeke et al. HEPATOLOGY
- Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
- (2013) Samuele De Minicis et al. HEPATOLOGY
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
- (2013) Steven M. Opal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
- (2013) Robert A Koeth et al. NATURE MEDICINE
- NAFLD, NASH and liver cancer
- (2013) Gregory A. Michelotti et al. Nature Reviews Gastroenterology & Hepatology
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Fecal Microbiota Transplantation — An Old Therapy Comes of Age
- (2013) Ciarán P. Kelly NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
- (2013) W.H. Wilson Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer
- (2013) Janelle C. Arthur et al. Scientific Reports
- Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide
- (2012) Ying-Ying Jing et al. BMC Medicine
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis
- (2012) G. Nkontchou et al. Cancer Prevention Research
- Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites
- (2012) Georgios N. Kalambokis et al. Clinical Gastroenterology and Hepatology
- High Prevalence of Antibiotic-Resistant Bacterial Infections Among Patients With Cirrhosis at a US Liver Center
- (2012) Puneeta Tandon et al. Clinical Gastroenterology and Hepatology
- Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
- (2012) Anne Vrieze et al. GASTROENTEROLOGY
- Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice
- (2012) Dewei Ye et al. GUT
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
- (2012) Jiannis Vlachogiannakos et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 964 THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) INCREASES PLASMA FGF-19 CONCENTRATIONS AND DECREASES BILE ACID SYNTHESIS IN PRIMARY BILIARY CIRRHOSIS (PBC)
- (2012) H.-U. Marschall et al. JOURNAL OF HEPATOLOGY
- Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
- (2012) Hui-Lu Zhang et al. JOURNAL OF HEPATOLOGY
- Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
- (2012) Derrick E. Fouts et al. JOURNAL OF HEPATOLOGY
- Functional interactions between the gut microbiota and host metabolism
- (2012) Valentina Tremaroli et al. NATURE
- Modulation of intestinal barrier by intestinal microbiota: Pathological and therapeutic implications
- (2012) Jane M.M. Natividad et al. PHARMACOLOGICAL RESEARCH
- Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut Microbiota
- (2012) N. Kamada et al. SCIENCE
- Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
- (2011) Francesco Peri et al. BIOTECHNOLOGY ADVANCES
- Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
- (2011) Amisha Barochia et al. Expert Opinion on Drug Metabolism & Toxicology
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
- (2011) Bin Gao et al. GASTROENTEROLOGY
- Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis
- (2011) Salvatore Modica et al. GASTROENTEROLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Characterization of fecal microbial communities in patients with liver cirrhosis
- (2011) Yanfei Chen et al. HEPATOLOGY
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study
- (2011) Javier Fernández et al. HEPATOLOGY
- DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
- (2011) Erwin Gäbele et al. JOURNAL OF HEPATOLOGY
- Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice
- (2011) Qiang Zhu et al. JOURNAL OF HEPATOLOGY
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
- (2010) Todd W. Rice et al. CRITICAL CARE MEDICINE
- Gut microbiota and probiotics in chronic liver diseases
- (2010) Claudia Cesaro et al. DIGESTIVE AND LIVER DISEASE
- Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis
- (2010) Pablo Bellot et al. HEPATOLOGY
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- The role of intestinal endotoxin in liver injury: A long and evolving history
- (2010) James P. Nolan HEPATOLOGY
- Enteric dysbiosis associated with a mouse model of alcoholic liver disease
- (2010) Arthur W. Yan et al. HEPATOLOGY
- Genetic Diversity and Virulence Profiles of Escherichia coli Isolates Causing Spontaneous Bacterial Peritonitis and Bacteremia in Patients with Cirrhosis
- (2010) F. Bert et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis
- (2010) Christian J Steib et al. LABORATORY INVESTIGATION
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
- (2010) A. J. Sanyal et al. ONCOLOGIST
- Toll-like Receptor 4 and Hepatic Fibrogenesis
- (2010) Jean-Philippe Pradere et al. SEMINARS IN LIVER DISEASE
- Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
- (2009) J. VLACHOGIANNAKOS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the management of hepatocellular carcinoma
- (2009) R. CABRERA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Oral Propranolol Decreases Intestinal Permeability in Patients With Cirrhosis: Another Protective Mechanism Against Bleeding?
- (2009) Marco Senzolo et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases
- (2009) Hoonmo L Koo et al. CURRENT OPINION IN GASTROENTEROLOGY
- Norfloxacin Modulates the Inflammatory Response and Directly Affects Neutrophils in Patients With Decompensated Cirrhosis
- (2009) Pedro Zapater et al. GASTROENTEROLOGY
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Glycolipids and Benzylammonium Lipids as Novel Antisepsis Agents: Synthesis and Biological Characterization
- (2009) Matteo Piazza et al. JOURNAL OF MEDICINAL CHEMISTRY
- β-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis
- (2009) Marco Senzolo et al. LIVER INTERNATIONAL
- Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog
- (2009) K. Machida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatitis C Virus and Alcohol
- (2009) Larry Siu et al. SEMINARS IN LIVER DISEASE
- Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice
- (2008) Mathieu Membrez et al. FASEB JOURNAL
- The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88
- (2008) Istvan Hritz et al. HEPATOLOGY
- Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis
- (2008) Rubén Francés et al. HEPATOLOGY
- A core gut microbiome in obese and lean twins
- (2008) Peter J. Turnbaugh et al. NATURE
- Targeting bile-acid signalling for metabolic diseases
- (2008) Charles Thomas et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started